References
- Arepally, G. M., & Padmanabhan, A. (2021). Heparin-induced thrombocytopenia: A focus on thrombosis. Arteriosclerosis, Thrombosis, and Vascular Biology, 41(1), 141–152. https://doi.org/10.1161/ATVBAHA.120.315445
- Center for Disease Control and Prevention. Vector viral vaccines. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/viralvector.html (accessed April 30, 2021).
- Cuker, A., Gimotty, P. A., Crowther, M. A., & Warkentin, T. E. (2012). Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: A systematic review and meta-analysis. Blood, 120(20), 4160–4167. https://doi.org/10.1182/blood-2012-07-443051
- Emergency Use Authorization (EUA) of the Janssen COVID-19 Vaccine to Prevent Coronavirus Disease (2019). (COVID-19) in individuals 18 years of age and older. https://www.fda.gov/media/146305/download (accessed April 22, 2021).
- Greinacher, A. (2015). Clinical practice. Heparin-induced thrombocytopenia. New England Journal of Medicine, 373(3), 252–261. https://doi.org/10.1056/NEJMcp1411910
- Greinacher, A., Thiele, T., Warkentin, T. E., Weisser, K., Kyrle, P. A., & Eichinger, S. (2021). Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. The New England Journal of Medicine. https://doi.org/10.1056/NEJMoa2104840
- Hendaus, M. A. (2020). Remdesivir in the treatment of coronavirus disease 2019 (COVID-19): A simplified summary. Journal of Biomolecular Structure & Dynamics, 1–6. Advance online publication. https://doi.org/10.1080/07391102.2020.1767691
- Hendaus, M. A., & Jomha, F. A. (2020a). Covid-19 induced superimposed bacterial infection. Journal of Biomolecular Structure & Dynamics, 1–7. Advance online publication. https://doi.org/10.1080/07391102.2020.1772110
- Hendaus, M. A., & Jomha, F. A. (2020b). From COVID-19 to clot: The involvement of the complement system. Journal of Biomolecular Structure & Dynamics, 1–6. Advance online publication. https://doi.org/10.1080/07391102.2020.1832919
- Hodgson, S. H., Mansatta, K., Mallett, G., Harris, V., Emary, K., & Pollard, A. J. (2021). What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2. The Lancet Infectious Diseases, 21(2), e26–e35. https://doi.org/10.1016/S1473-3099(20)30773-8
- Information for Healthcare Professionals on COVID-19 Vaccine AstraZeneca. https://www.gov.uk/government/publications/regulatory-approval-of-covid-19-vaccine-astrazeneca/information-for-healthcare-professionals-on-covid-19-vaccine-astrazeneca (accessed April 22, 2021).
- Jaax, M. E., Krauel, K., Marschall, T., Brandt, S., Gansler, J., Fürll, B., Appel, B., Fischer, S., Block, S., Helm, C. A., Müller, S., Preissner, K. T., & Greinacher, A. (2013). Complex formation with nucleic acids and aptamers alters the antigenic properties of platelet factor 4. Blood, 122(2), 272–281. https://doi.org/10.1182/blood-2013-01-478966
- Ledford, H. (2021). COVID vaccines and blood clots: Five key questions. Nature, 592, 495–496. https://doi.org/10.1038/d41586-021-00998-w (accessed April 22, 2021).
- Marcucci, R., Berteotti, M., Gori, A. M., Giusti, B., Rogolino, A. A., Sticchi, E., Liotta, A. A., Ageno, W., De Candia, E., Gresele, P., Marchetti, M., Marietta, M., & Tripodi, A. (2021). Heparin induced thrombocytopenia: Position paper from the Italian Society on Thrombosis and Haemostasis (SISET). Blood Transfusion = Trasfusione Del Sangue, 19(1), 14–23. https://doi.org/10.2450/2020.0248-20
- Muir, K. L., Kallam, A., Koepsell, S. A., & Gundabolu, K. (2021). Thrombotic thrombocytopenia after Ad26.COV2.S vaccination. The New England Journal of Medicine, https://doi.org/10.1056/NEJMc2105869
- Schultz, N. H., Sørvoll, I. H., Michelsen, A. E., Munthe, L. A., Lund-Johansen, F., Ahlen, M. T., Wiedmann, M., Aamodt, A. H., Skattør, T. H., Tjønnfjord, G. E., & Holme, P. A. (2021). Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination. The New England Journal of Medicine, https://doi.org/10.1056/NEJMoa2104882.Advance online publication. https://doi.org/10.1056/NEJMoa2104882
- Scully, M., Singh, D., Lown, R., Poles, A., Solomon, T., Levi, M., Goldblatt, D., Kotoucek, P., Thomas, W., & Lester, W. (2021). Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination. The New England Journal of Medicine, https://doi.org/10.1056/NEJMoa2105385
- von Hundelshausen, P., Lorenz, R., Siess, W., & Weber, C. (2021). Vaccine-induced immune thrombotic thrombocytopenia (VITT): targeting pathomechanisms with Bruton tyrosine kinase inhibitors. Thrombosis and Haemostasis,10.1055/a-1481-3039. Advance online publication. https://doi.org/10.1055/a-1481-3039
- WHO Coronavirus Disease [COVID-19] Dashboard, as on 21 April 2021. https://covid19.who.int/?adgroupsurvey={adgroupsurvey}&gclid=CjwKCAjwmv-DBhAMEiwA7xYrdx0TDpGyykFeM5s4flbnIWXNBJyhR9wIjVSO7JIseLwtmXRcUwVJlhoCyTQQAvD_BwE (accessed April 21, 2021).